Gasser I. Azab-El

Menoufia, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial.

Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial.

Journal: Helicobacter

Published: November 24, 2025

Hepatogenous diabetes in the era of precision medicine: diagnosis, management, and future directions.

Hepatogenous diabetes in the era of precision medicine: diagnosis, management, and future directions.

Journal: Clinical and experimental medicine

Published: November 14, 2025

Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study.

Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study.

Journal: Scientific reports

Published: August 27, 2025

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications.

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications.

Journal: Clinical and experimental medicine

Published: July 18, 2025

Association of small intestinal bacterial overgrowth with portal hypertension in HCV-related cirrhosis: a cross-sectional study.

Association of small intestinal bacterial overgrowth with portal hypertension in HCV-related cirrhosis: a cross-sectional study.

Journal: Clinical and experimental medicine

Published: July 06, 2025

Efficacy and safety of immediate vs. delayed endoscopic retrieval of large or multiple common bile duct stones in high-risk elderly patients: a prospective, randomized comparative study.

Efficacy and safety of immediate vs. delayed endoscopic retrieval of large or multiple common bile duct stones in high-risk elderly patients: a prospective, randomized comparative study.

Journal: Clinical and experimental medicine

Published: March 31, 2025

Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks.

Proton Pump Inhibitors in Patients with Cirrhosis: Pharmacokinetics, Benefits and Drawbacks.

Journal: Current gastroenterology reports

Published: August 01, 2024

Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases.

Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases.

Journal: World journal of gastroenterology

Published: December 07, 2022

Prevalence and predictors of post-liver transplantation metabolic bone diseases.

Prevalence and predictors of post-liver transplantation metabolic bone diseases.

Journal: Clinical and experimental hepatology

Published: February 06, 2021

Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.

Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.

Journal: European journal of gastroenterology & hepatology

Published: April 21, 2016

Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.

Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study.

Journal: Hepatology international

Published: July 28, 2015

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis.

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis.

Journal: International journal of hepatology

Published: July 13, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026